Catechol-O-methyltransferase genotype modulates cancer treatment-related cognitive deficits in breast cancer survivors (Q83676581)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21425136%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

title

Catechol-O-methyltransferase genotype modulates cancer treatment-related cognitive deficits in breast cancer survivors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21425136%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21425136%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Paul B. Jacobsen

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21425136%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

author name string

Kerri Sharp Rawson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21425136%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Erin Walsh

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21425136%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Heather S L Jim

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21425136%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Tiffany F Hughes

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21425136%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Lindsay Iser

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21425136%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Michael A Andrykowski

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21425136%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

publication date

8 November 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21425136%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21425136%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

volume

117

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21425136%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21425136%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

page(s)

1369-1376

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21425136%20AND%20SRC:MED&resulttype=core&format=json

Candidate mechanisms for chemotherapy-induced cognitive changes

26 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25685

7 January 2021

Cognitive adverse effects of chemotherapy in breast cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25685

7 January 2021

Cognitive functioning in breast cancer survivors: a controlled comparison

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25685

7 January 2021

Neuropsychological effects of treatments for adults with cancer: a meta-analysis and review of the literature

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25685

7 January 2021

The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: a meta-analysis of the current literature.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25685

7 January 2021

What is the effect of systemic anticancer treatment on cognitive function?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25685

7 January 2021

Cognitive impairment associated with chemotherapy for cancer: report of a workshop

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25685

7 January 2021

Predictors of cognitive decline after chemotherapy in breast cancer patients.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25685

7 January 2021

The relationship of APOE genotype to neuropsychological performance in long-term cancer survivors treated with standard dose chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25685

7 January 2021

Apolipoprotein E and cognitive performance: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25685

7 January 2021

The molecular genetics of cognition: dopamine, COMT and BDNF.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25685

7 January 2021

Genes and the parsing of cognitive processes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25685

7 January 2021

Human aging magnifies genetic effects on executive functioning and working memory

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25685

7 January 2021

Brain structure and function differences in monozygotic twins: possible effects of breast cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25685

7 January 2021

Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5-10 years after chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25685

7 January 2021

Attitudes toward information about genetic risk for cognitive impairment after cancer chemotherapy: breast cancer survivors compared with healthy controls

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25685

7 January 2021

Cognitive functioning after adjuvant chemotherapy and/or radiotherapy for early-stage breast carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25685

7 January 2021

The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25685

7 January 2021

Change in cognitive function after chemotherapy: a prospective longitudinal study in breast cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25685

7 January 2021

Late effects of adjuvant chemotherapy on cognitive function: a follow-up study in breast cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25685

7 January 2021

Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25685

7 January 2021

Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25685

7 January 2021

Peripheral neuropathy induced by microtubule-stabilizing agents.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25685

7 January 2021

Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25685

7 January 2021

Executive subprocesses in working memory: relationship to catechol-O-methyltransferase Val158Met genotype and schizophrenia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25685

7 January 2021

Meta-analysis of the cognitive effects of the catechol-O-methyltransferase gene Val158/108Met polymorphism

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25685

7 January 2021

Genomic medicine--a primer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25685

7 January 2021

The Path to Personalized Medicine

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25685

7 January 2021

Identifiers

DOI

10.1002/CNCR.25685

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21425136%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

1 reference